Disrupting a negative feedback loop drives endocrine therapy-resistant breast cancer [Medical Sciences]
According to the American Cancer Society, 266,120 women in the United States will be diagnosed with breast cancer and 40,920 will die in 2018 (1). Approximately 70% of all these breast cancers express estrogen receptor α (ERα) and are initially treated with endocrine therapies that target this nuclear hormone receptor...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Charles E. Foulds Tags: Commentaries Source Type: research
More News: Academies | Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Hormones | USA Health | Women